James P. D'apolito MD Pediatrics, INC.

James P. D'apolito MD Pediatrics, INC. was paid $1.07M by Medicaid between Jan 2018 and Dec 2024, across 44 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 23% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	4,700	$96K
2019	5,928	$150K
2020	5,694	$146K
2021	7,281	$219K
2022	7,902	$204K
2023	7,039	$171K
2024incomplete	2,614	$79K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	23%	6,208	5,559	$248K
90460	Immunization administration through 18 years of age via any route, first or only component	16%	5,420	4,575	$174K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	13%	2,315	2,149	$140K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	12%	2,561	2,314	$127K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	12%	2,197	2,102	$125K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	5.1%	986	951	$55K
96110	Developmental screening, with scoring and documentation, per standardized instrument	4.2%	5,787	5,506	$45K
99460		3.0%	474	442	$32K
90670		2.2%	1,835	1,738	$23K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	1.7%	293	282	$19K
99238	Hospital discharge day management, 30 minutes or less	1.6%	586	559	$18K
90698		<1%	1,729	1,628	$9K

32 more codes

88738		<1%	2,366	$9K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	810	$8K
92552		<1%	697	$8K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	177	$4K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	325	$3K
90716		<1%	297	$3K
87081		<1%	504	$2K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	64	$2K
90633		<1%	645	$1K
99401		<1%	162	$1K
90680		<1%	1,246	$1K
90744		<1%	1,005	$1K
85018		<1%	559	$1K
90686		<1%	531	$798.49
90707		<1%	324	$766.78
54450		<1%	12	$622.68
90671		<1%	384	$515.41
99173		<1%	253	$483.93
99462		<1%	13	$415.12
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	32	$332.71
69210		<1%	24	$292.88
69209		<1%	25	$169.14
A7003	Administration set, with small volume nonfiltered pneumatic nebulizer, disposable	<1%	28	$35.71
90647		<1%	43	$16.00
90700		<1%	43	$15.30
90734		<1%	15	$12.00
90715		<1%	14	$9.00
90619		<1%	15	$9.00
90710		<1%	16	$8.00
90461		<1%	65	$5.00
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	29	$0.13
94760		0%	44	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialD'APOLITO, JAMES (PRESIDENT)